skip to Main Content

BCBS Horizon Medical Policy Updates – October 2018

BCBS Horizon Medical Policy Updates – October 2018
BCBS Horizon NJ Medical Policy Updates

Click here to view the Blue Cross Blue Shield Horizon Medical Policy Updates »

October 2018 Medical Policy Updates:

  • Agalsidase Beta (Fabrazyme)
  • Allogeneic Pancreas Transplant
  • Assisted Reproductive Technologies
  • Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
  • Belimumab (Benlysta)
  • Biofeedback
  • Botulinum Toxin
  • Chiropractic Review Policy
  • Composite Tissue Allotransplantation of the Hand and Face
  • Computed Tomography (CT) Perfusion Imaging of the Brain
  • Discography
  • Drug Therapy for Hereditary Angioedema [Cinryze Berinert Haegarda (Human C1 Inhibitor) Kalbitor (Ecallantide) Firazyr (Icatibant) Ruconest (C1 Esterase Inhibitor [Recombinant])]
  • Eculizumab (Soliris)
  • Epidural Steroid Injections
  • Epidurography Radiological Supervision and Interpretation
  • Facet Joint Injections or Medial Branch Blocks
  • First Trimester Screening for Chromosomal Abnormalities using Fetal Ultrasound Assessment of Nuchal Translucency Combined with Maternal Serum Assessment
  • Foot Care Services
  • Gait Trainers and Standing Frames
  • Gaucher Disease Therapy
  • Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
  • Gonadotropin-Releasing Hormone Analogs
  • Heart or Lung Transplant
  • Heart Transplant
  • Immune Globulin Subcutaneous (Vivaglobin Hizentra Gammagard Liquid Gamunex-C or Gammaked HyQvia and Cuvitru for Subcutaneous Administration)
  • Implantable Intrathecal Drug Delivery Systems
  • Injectable Bulking Agents for the Treatment of Urinary Incontinence
  • Intravenous Immunoglobulin (IVIG) Therapy
  • Invasive Prenatal (Fetal) Diagnostic Testing
  • Islet Transplantation
  • Isolated Small Bowel Transplant
  • Kidney Transplant
  • Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
  • Laronidase (Aldurazyme) Galsulfase (Naglazyme) and Idursulfase (Elaprase) elosulfase alfa (Vimizim) and vestronidase alfa (Mepsevii)
  • Liver Transplant and Combined Liver-Kidney Transplant
  • Lung and Lobar Lung Transplant
  • Meniscal Allografts and Other Meniscal Implants
  • Multigene Expression Assay for Predicting Recurrence in Colon Cancer
  • Nivolumab (Opdivo)
  • Ovarian and Internal Iliac Vein Embolization as a Treatment of Pelvic Congestion Syndrome
  • Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
  • Pemetrexed Disodium (Alimta)
  • Percutaneous Neurolysis for Trigeminal Neuralgia
  • Percutaneous Tibial Nerve Stimulation
  • Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR)
  • Pompe Disease Treatment with Myozyme (Alglucosidase alfa) and Lumizyme (Alglucosidase alfa)
  • Preimplantation Genetic Testing
  • Radiofrequency Joint Ablation or Denervation
  • Regional Sympathetic Blocks
  • Rhinomanometry and Acoustic or Optical Rhinometry
  • Sacroiliac Joint Injections
  • Scintimammography and Gamma Imaging of the Breast and Axilla
  • Serum Biomarker Tests for Multiple Sclerosis
  • Site of Service for Administration for Infusion and Injectable Prescription Medications
  • Small Bowel or Liver and Multivisceral Transplant
  • Spinal Cord and Implantable Peripheral Nerve Stimulators
  • Standards for Diagnostic Radiology or Imaging Facilities or Freestanding-Office including Surgi-Centers and Diagnostic Dental – Radiographic Imaging
  • Thermography
  • Total Artificial Hearts and Implantable Ventricular Assist Devices
  • Trastuzumab (Herceptin) Trastuzumab-dkst (Ogivri) and Ado-trastuzumab emtansine (Kadcyla)
  • Trigger Point Injections
  • Unna Boot
  • Ustekinumab (Stelara)
  • Vitrectomy Chair or Vitrectomy Support System or Face-Down Positioning Device for Post-Vitrectomy Positioning
  • Whole Body Dual X-Ray Absorptiometry (DEXA) to Determine Body Composition
  • Work Hardening or Conditioning Programs
  • Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
  • Bioengineered Skin and Soft Tissue Substitutes
  • Bone Mineral Density Studies and Vertebral Fracture Assessment With Densitometry
  • Dermatologic Applications of Photodynamic Therapy
  • Erwinaze (Asparaginase Erwinia Chrysanthemi) and Oncaspar (pegaspargase)
  • Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
  • Hip Resurfacing
  • Non Oral Drug Therapy for Pulmonary Hypertension
  • Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA
  • Obstetrical Ultrasound Policy
  • Photodynamic Therapy for Choroidal Neovascularization
  • Total Ankle Replacement (Arthroplasty)
  • Transplant Donor and Recipient Policy

 

Click here to view the Blue Cross Blue Shield Horizon Medical Policy Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top